Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (SGMO), Deciphera Pharmaceuticals (DCPH) and Viemed Healthcare (VMD).
Sangamo Biosciences (SGMO)
In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Sangamo Biosciences, with a price target of $11.00. The company’s shares closed last Tuesday at $11.36.
According to TipRanks.com, Moussatos is a 4-star analyst with an average return of 8.4% and a 41.3% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Eiger Biopharmaceuticals, and BioMarin Pharmaceutical.
Currently, the analyst consensus on Sangamo Biosciences is a Moderate Buy with an average price target of $20.40.
See today’s analyst top recommended stocks >>
Deciphera Pharmaceuticals (DCPH)
Deciphera Pharmaceuticals received a Buy rating from JonesTrading analyst Soumit Roy today. The company’s shares closed last Tuesday at $43.29, close to its 52-week low of $39.42.
According to TipRanks.com, Roy is a 5-star analyst with an average return of 47.2% and a 48.3% success rate. Roy covers the Healthcare sector, focusing on stocks such as Monopar Therapeutics Inc, Adaptimmune Therapeutics, and Aeglea Biotherapeutics.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Deciphera Pharmaceuticals with a $72.00 average price target, which is a 57.9% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $60.00 price target.
Viemed Healthcare (VMD)
Bloom Burton analyst Prasath Pandurangan maintained a Buy rating on Viemed Healthcare today. The company’s shares closed last Tuesday at $9.77.
Pandurangan has an average return of 130.4% when recommending Viemed Healthcare.
According to TipRanks.com, Pandurangan is ranked #3186 out of 7490 analysts.
Viemed Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $13.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
